Berend Snijder
Researcher · Founder
Now Founder, Prevision Medicine
Latest on AI4S.fyiFunding · Sep 24 · founderPrevision Medicine · Seed · $5.4MAccount linked from snijderlab.org · Avatar from their X account, taken 2026-09-28
Affiliations
Current
- Founder · Prevision Medicine
Also named in the companies' announcements: ETH Zurich
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
About
Berend Snijder is the scientific co-founder and chairman of Prevision Medicine, whose pharmacoscopy technology came out of his research. He is a faculty member at the Botnar Institute of Immune Engineering, a group leader at the Swiss Institute of Bioinformatics and the Comprehensive Cancer Center Zurich, and a former assistant professor at ETH Zurich. His research profiles human tissues functionally and with multi-omics, and he also co-founded Allcyte and Graph Therapeutics.
Read on 2026-09-29; for current roles see Affiliations above. Read at: previsionmedicine.com ↗ · snijderlab.org ↗
Founded
Prevision MedicineBiology data and tools · 2024 · 1 round on record · disclosed $5.4M · Seed $5.4MBackground: Former assistant professor at ETH Zurich; also co-founded Allcyte and Graph Therapeutics (scientific co-founder, chairman) (as the company's own announcements put it)
Co-founders: Philip Zimmermann, Valentin Matillon, Yannik Severin
Backed byACE Ventures
Nothing else on the record names them yet.
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →